CHG-2023-0114
Formulation Change for Semaglutidex. Labeling Change for Semaglutidex — critical change. Impacts 1 markets and 2 variations.
Change Number
CHG-2023-0114
Type
Formulation Change
Product
Status
Active
Owner
Priya Sharma
Initiated
2022-06-12
Description
Labeling Change for Semaglutidex — critical change
Impacted Markets (1)
JP — Japan
Impacted Modules
2.3.P3.2.P5.3.5
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|